Ioflupane I 123

Records for this ingredient, by country (identity only).

ATC V09AB03 · 3 markets · 11 records

Ioflupane I 123 3 markets · 11 records Forms
Filters
MarketGB 6FR 3US 2

GB 6 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

  • 5 mL per mL / per unit basis not statedinjectionDaTSCAN [I-123] 370MBq/5ml solution for injection vialsStriascan [I-123] 370MBq/5ml solution for injection vials、Manufacturer: Curium Pharma UK Ltd
  • 2.5 mL per mL / per unit basis not statedinjectionDaTSCAN [I-123] 185MBq/2.5ml solution for injection vialsStriascan [I-123] 185MBq/2.5ml solution for injection vials、Manufacturer: Curium Pharma UK Ltd

FR 3 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 74 MBq/1 mLinjectionDATSCAN 74 MBq/ml, solution injectableIOFLUPANE (123I) ROTOP 74 MBq/ml solution injectable、STRIASCAN 74 MBq/mL, solution injectable

US 2 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 2 mCi per mL / per unit basis not statedinjectionDaTscanIoflupane I 123

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.